Brain bleed clot dissolving with tNK for stroke recovery
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a clot-busting drug called tenecteplase given directly into the brain bleed through a thin tube. It may help reduce damage and improve recovery for people with a certain type of brain hemorrhage.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You had a sudden brain bleed in the upper part of your brain (not the brainstem or cerebellum) confirmed by a CT scan within 24 hours of when symptoms started or when you were last seen normal.
- The bleed is between about 1.5 and 3.5 tablespoons in size (25 to 60 mL).
- You have some weakness, numbness, or trouble speaking (NIHSS score of 6 or more) but are not in a coma (GCS score between 9 and 14).
- You were able to do your usual daily activities before the stroke (mRS score 0 or 1).
- You are not pregnant, have no bleeding disorders, and have not taken blood thinners like warfarin in the past week.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a clot-dissolving drug called tenecteplase can improve recovery for people who had a large-vessel ischemic stroke 4.5 to 24 hours earlier and can’t have a mechanical clot removal procedure in time. If you join, you’ll get either tenecteplase or standard medical care, and the study will track your recovery and safety.
This trial tests a clot-busting medication (tenecteplase, or TNK) to see if it can safely break down the blood clot in your brain after a large bleed. If you are eligible, you may receive this treatment to help your body reabsorb the clot.
This trial looks at giving a clot-busting medicine directly into the brain arteries (intra-arterial TNK) when a stroke procedure (thrombectomy) doesn’t reopen the blocked vessel enough. It aims to improve recovery by improving blood flow while checking for safety, especially bleeding risk.
This trial tests a minimally invasive procedure to remove deep brain bleeds using a special puncture guided by brain imaging, combined with a clot-dissolving drug called tenecteplase. It may help reduce damage from the bleed and improve recovery.
This trial tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after a successful mechanical clot removal can improve recovery for people with a certain type of stroke. The goal is to see if it safely helps clear any remaining tiny clots and reduces disability.
This trial tests a clot-busting drug called tenecteplase given directly into the brain artery for people having a moderate stroke caused by a blockage in a medium-sized blood vessel. The goal is to see if it helps improve recovery when given within 24 hours of stroke symptoms starting.
Hear when a new Intracerebral Haemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.